申请人:Umemiya Hiroki
公开号:US20100190980A1
公开(公告)日:2010-07-29
Disclosed is a pyrazinamide compound represented by the formula (1), a tautomer, stereoisomer or pharmaceutically acceptable salt thereof, or a solvate of the compound or the tautomer, stereoisomer or pharmaceutically acceptable salt thereof, which has an excellent GK-activating activity and is therefore useful as a medicinal agent. (1) wherein R
1
represents a hydrogen atom, a C
1-8
alkyl group, a C
3-8
cycloalkyl group, a C
2-9
heterocyclyl group, a phenyl group, a C
1-9
heteroaryl group, a C
7-14
arylalkyl group or the like; R
2
represents a C
1-8
alkyl group, a C
2-9
heterocyclyl group, a phenyl group, a C
1-9
heteroaryl group or the like; Ar represents a monocyclic or fused polycyclic C
1-9
heteroaryl group represented by the formula (2) or a C
2-9
heterocyclyl group represented by formula (2); Y represents —S—, —O— or —NH—; and Z represents —S—, —O— or —CH
2
—.
本发明公开了一种吡嗪酰胺化合物,其由式(1)表示,其中R1代表氢原子、C1-8烷基、C3-8环烷基、C2-9杂环基、苯基、C1-9杂环基、C7-14芳基烷基等;R2代表C1-8烷基、C2-9杂环基、苯基、C1-9杂环基等;Ar代表由式(2)表示的单环或融合多环的C1-9杂环基或由式(2)表示的C2-9杂环基;Y代表—S—、—O—或—NH—;Z代表—S—、—O—或—CH2—。该化合物或其互变异构体、立体异构体、药学上可接受的盐或其溶剂,具有出色的GK激活活性,因此作为药物剂使用。